Related Experiment Video
Updated: Jan 9, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
A Study of the Correlation Between the Inflammatory Index and Disease Activity in Ulcerative Colitis
Zhang Chenfei1, Zubiyan Ainiwaer1, Huang Xiaoling1
1Xinjiang Uygur Autonomous Region People's Hospital, Urumqi, Xinjiang Uygur Autonomous Region, People's Republic of China.
Objective:
To analyze the level of systemic immune-inflammatory index (SII) in patients with ulcerative colitis (UC) and assess its relationship with disease activity.
Methods:
This study included 616 UC patients and 211 healthy controls. Disease activity was assessed using the modified Mayo score, categorizing patients into remission (n=115) and active (n=501) groups, with the latter further stratified into mild, moderate, and severe activity. We compared multiple inflammatory indices-including SII, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil percentage-albumin ratio (NPAR), and others-between groups. Spearman correlation and ROC curve analyses were used to evaluate their associations with disease activity and predictive value for active and severe UC.
Results:
SII, NLR, PLR, NPAR, and several other indices were significantly higher in the UC group than controls, while lymphocyte-to-monocyte ratio (LMR) and LHR were lower (all P<0.05). Most indices were also elevated in active versus remission UC (P<0.05), and showed significant differences across severity subgroups (P<0.05), with SII, NLR, NPAR, NHR, and MHR increasing with severity. Spearman analysis revealed positive correlations between these markers and disease activity/severity (P<0.001). ROC analysis demonstrated significant predictive value for active and severe UC (AUC>0.60, P<0.001), with NPAR exhibiting the highest efficacy (AUC=0.854).
Conclusion:
SII, NLR, PLR, NPAR, and other inflammatory indices are useful non-invasive biomarkers for assessing UC disease activity and severity, with NPAR showing the strongest predictive performance.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

